Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations

Nature Communications

Volumn 7, Issue , 2016, Pages

  Roberti, Annalisa ^a   Dobay, Maria Pamela ^b   Bisig, Bettina ^a   Vallois, David ^a   Boéchat, Cloé ^a   Lanitis, Evripidis ^c   Bouchindhomme, Brigitte ^d   Parrens, Marie Cécile ^e   Bossard, Céline ^f   Quintanilla Martinez, Leticia ^g   Missiaglia, Edoardo ^a,b   Gaulard, Philippe ^h   De Leval, Laurence ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^d UNIV LILLE   (France)

^e HAUT LÉVÊQUE HOSPITAL   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^h HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; HISTONE ACETYLTRANSFERASE; JANUS KINASE; JANUS KINASE 3; K RAS PROTEIN; STAT PROTEIN; STAT5B PROTEIN; TRANSFERASE; HISTONE LYSINE METHYLTRANSFERASE; SET2 PROTEIN, HUMAN;

CELLS AND CELL COMPONENTS; DIGESTIVE SYSTEM DISORDER; GENE; GENE EXPRESSION; GENOMICS; MOLECULAR ANALYSIS; MUTATION; TUMOR;

ARTICLE; CHROMOSOME 3P; CONTROLLED STUDY; DNA METHYLATION; DNA SPLICING; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; ENZYME ACTIVATION; EXOME; FRAMESHIFT MUTATION; GENE INACTIVATION; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENOME; HETEROZYGOTE; HUMAN; HUMAN TISSUE; INDEL MUTATION; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; SETD2 GENE; TUMOR SUPPRESSOR GENE; TYPE 2 ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOMICS; INTESTINE TUMOR; MUTATION; PHYSIOLOGY;

ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; INTESTINAL NEOPLASMS; MUTATION;

EID: 84986569401     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12602     Document Type: Article

References (58)

1. Swerdlow, S. H. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (International Agency for Research on Cancer, Northwestern University, 2008).
2. Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375-2390 (2016).
3. Foukas, P. G., de Leval, L. Recent advances in intestinal lymphomas. Histopathology 66, 112-136 (2015).
4. Delabie, J. et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 118, 148-155 (2011).
5. Chan, J. K. et al. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am. J. Surg. Pathol. 35, 1557-1569 (2011).
6. Nijeboer, P. et al. Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort. Am. J. Hematol. 90, 493-498 (2015).
7. Ko, Y. H. et al. Enteropathy-associated T-cell lymphoma- A clinicopathologic and array comparative genomic hybridization study. Hum. Pathol. 41, 1231-1237 (2010).
8. Deleeuw, R. J. et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132, 1902-1911 (2007).
9. Tomita, S. et al. Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan. Mod. Pathol. 28, 1286-1296 (2015).
10. Nairismagi, M. L. et al. JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia 30, 1311-1319 (2016).
11. Kucuk, C. et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells. Nat. Commun. 6, 6025 (2015).
12. Pasqualucci, L. et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471, 189-195 (2011).
13. Morin, R. D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42, 181-185 (2010).
14. Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157-163 (2012).
15. Lemonnier, F. et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 120, 1466-1469 (2012).
16. Cairns, R. A. et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 119, 1901-1903 (2012).
17. Couronne, L., Bastard, C., Bernard, O. A. TET2 and DNMT3A mutations in human T-cell lymphoma. N. Engl. J. Med. 366, 95-96 (2012).
18. Li, M. et al. Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1. Proc. Natl Acad. Sci. USA 102, 17636-17641 (2005).
19. Worth, C. L., Preissner, R., Blundell, T. L. SDM- A server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Res. 39, W215-W222 (2011).
20. Yin, S., Ding, F., Dokholyan, N. V. Eris: an automated estimator of protein stability. Nat. Methods 4, 466-467 (2007).
21. Edmunds, J. W., Mahadevan, L. C., Clayton, A. L. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J. 27, 406-420 (2008).
22. Ho, T. H. et al. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene 35, 1565-1574 (2015).
23. Yamashita, Y. et al. Array-based genomic resequencing of human leukemia. Oncogene 29, 3723-3731 (2010).
24. Kiel, M. J. et al. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. Blood 124, 1460-1472 (2014).
25. Koo, G. C. et al. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. Cancer Discov. 2, 591-597 (2012).
26. Perez-Garcia, A. et al. Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood 122, 2425-2432 (2013).
27. Crescenzo, R. et al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell 27, 516-532 (2015).
28. Koskela, H. L. et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N. Engl. J. Med. 366, 1905-1913 (2012).
29. Kudithipudi, S., Jeltsch, A. Role of somatic cancer mutations in human protein lysine methyltransferases. Biochim. Biophys. Acta 1846, 366-379 (2014).
30. Dalgliesh, G. L. et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360-363 (2010).
31. Al Sarakbi, W. et al. The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer 9, 290 (2009).
32. Fontebasso, A. M. et al. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol. 125, 659-669 (2013).
33. Zhu, X. et al. Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat. Genet. 46, 287-293 (2014).
34. Huang, K. K. et al. SETD2 histone modifier loss in aggressive GI stromal tumours. Gut. doi:10.1136/gutjnl-2015-309482 (2015).
35. Mar, B. G. et al. Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. Nat. Commun. 5, 3469 (2014).
36. Luscan, A. et al. Mutations in SETD2 cause a novel overgrowth condition. J. Med. Genet. 51, 512-517 (2014).
37. Jerez, A. et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood 120, 3048-3057 (2012).
38. O'Shea, J. J. et al. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu. Rev. Med. 66, 311-328 (2015).
39. Meresse, B., Korneychuk, N., Malamut, G., Cerf-Bensussan, N. Interleukin-15, a master piece in the immunological jigsaw of celiac disease. Dig. Dis. 33, 122-130 (2015).
40. Shitara, S. et al. IL-7 produced by thymic epithelial cells plays a major role in the development of thymocytes and TCRgammadelta\+ intraepithelial lymphocytes. J. Immunol. 190, 6173-6179 (2013).
41. Nicolae, A. et al. Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas. Leukemia 28, 2244-2248 (2014).
42. Rane, S. G., Reddy, E. P. Janus kinases: components of multiple signaling pathways. Oncogene 19, 5662-5679 (2000).
43. Pfister, S. X. et al. Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation. Cancer Cell 28, 557-568 (2015).
44. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
45. Li Aligning sequence reads, clone sequences and assembly contigs with BWAMEM. arXiv:1303.3997v1 (2013).
46. Koboldt, D. C. et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568-576 (2012).
47. Wang, K., Li, M., Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
48. Fajardo, K. F. V. et al. Detecting false-positive signals in exome sequencing. Hum. Mutat. 33, 609-613 (2012).
49. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
50. Olshen, A. B. et al. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostat. 5, 557-572 (2004).
51. Capriotti, E., Fariselli, P., Casadio, R. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 33, W306-W310 (2005).
52. Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res. 33, W382-W388 (2005).
53. Dehouck, Y., Kwasigroch, J. M., Gilis, D., Rooman, M. PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality. BMC Bioinformatics 12, 151 (2011).
54. Pires, D. E., Ascher, D. B., Blundell, T. L. DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Res. 42, W314-W319 (2014).
55. Smith, R. E., Lovell, S. C., Burke, D. F., Montalvao, R. W., Blundell, T. L.,ante: reducing side-chain rotamer search space during comparative modeling using environment-specific substitution probabilities. Bioinformatics 23, 1099-1105 (2007).
56. Huether, R. et al. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat. Commun. 5, 3630 (2014).
57. Hochberg, Y., Benjamini, Y. More powerful procedures for multiple significance testing. Stat. Med. 9, 811-818 (1990).
58. Bisig, B. et al. CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. Haematologica 98, 1250-1258 (2013).